选择性终止:对于复杂的单胆子妊娠来说,这是一个拯救生命的程序
Ali Javinani1, Ramesha Papanna2, Tim Van Mieghem3,4
1Fetal Care and Surgery Center (FCSC), Division of Fetal Medicine and Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Journal of perinatal medicine
|December 24, 2024
概括
选择性终止在单胞胎双胞胎怀孕可以拯救一个健康的胎儿,当一个双胞胎面临子宫内死亡. 这种程序旨在最大限度地提高幸存的双胞胎的健康和生命,特别是当干预措施失败时.
科学领域:
- 周围生理学 周围生理学
- 胎儿医学 胎儿医学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 双胞胎怀孕共享胎盘血管,增加风险.
- 解剖器血管可能会导致严重的并发症,包括巨大的血液转移,如果一个双胞胎死亡.
- 这种血液转移危及幸存的双胞胎的生命和神经发育结果.
研究的目的:
- 讨论一胎双胞胎子宫内死亡的影响.
- 突出产科医生在处理此类病例时的道德义务.
- 倡导选择性终止作为一种可行的选择,以改善幸存的双胞胎的结果.
主要方法:
- 对单双胞胎怀孕并发症的审查.
- 对胎儿干预无效的场景的分析.
- 关于患者自主权和福利的伦理考虑.
主要成果:
- 一个双胞胎的子宫内死亡导致了关键的血液转移,影响了双胞胎.
- 选择性胎儿生长限制和双胞胎输血等条件存在重大风险.
- 在这些复杂的病例中,胎儿干预可能无法有效地预防不良结果.
结论:
- 选择性终止是一种最大限度地提高幸存双胞胎健康的策略.
- 产科医生必须平衡患者的自主权与对两个胎儿的益处.
- 政策考虑应包括选择性终止作为堕胎禁令的例外.
更多相关视频
09:52Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye
Published on: September 5, 2011
26.8K
09:51Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators
Published on: March 21, 2018
19.6K
相关概念视频
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Meiosis vs. Mitosis
52.7K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
52.7K
Ovarian Cycle
993
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
993
Meiosis II
182.8K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
182.8K
